Hims & Hers Health, Inc. Chief Medical Officer Carroll Patrick Harrison sold 23,726 shares on June 18, 2026, at $35.00 per share, for a total of about $830,410. The transaction was made under a pre-scheduled Rule 10b5-1 trading plan, which is a preset program that allows insiders to trade on a schedule set in advance, helping reduce concerns that the trade was based on nonpublic information. This matters because a chief medical officer is a senior executive tied closely to clinical strategy, product safety, and regulatory considerations—areas retail investors often watch for signs of confidence or concern. However, the use of a 10b5-1 plan generally makes the timing less informative than an open-market sale decided in the moment, and it can also reflect routine financial planning such as diversification or tax needs. The sale also comes amid other insider selling in the last month: Okupe Oluyemi sold roughly $619,220 on June 22, 2026. With multiple sales close together, investors typically look for whether trades are part of planned programs and whether there are offsetting insider purchases, but based on the information provided, there isn’t enough to draw a clear directional takeaway.